Cookie policy

This site uses cookies to improve your user experience. By using this website, you agree that we can place cookies on your device. For further information, please read our Privacy And Cookies Policy

I accept the terms and conditions
Skip Ribbon Commands
Skip to main content

SurGuard®3

Safety Hypodermic Needles

Description

​SurGuard®3 Safety Hypodermic Needles

SurGuard®3 Safety Hypodermic Needles featured by Terumo Pharmaceutical Solutions are equipped with a three-way needlestick protection system and utilize Terumo’s T-Sharp
™ technology – offering Terumo quality needles to decrease penetration resistance1

Characteristics

Simple and comfortable injections

SurGuard®3 Safety Hypodermic Needles offer Terumo’s T-SharpTM triple-bevel lancet point1.

Designed to cover subcutaneous, intramuscular and intravenous injections, SurGuard®3 Safety Hypodermic Needles offer the necessary quality and supply reliability drug developers need to meet parenteral delivery challenges and product commercialization goals. 

Convenient administration

  • Three-way activation: hard surface, finger, or thumb to suit clinician preference
  • Patented, reliable, hinged sheath design provides an audible, visible, and tangible confirmation of safety2
  • Thin-wall needles3 
  • Sheath locks to both the needle and hub
  • Finger and thumb grips ergonomically engineered to be suitable for all hand sizes
  • Soft blister for easy handling – as well as for use as packaging, alternatives available upon request

Regulatory and Quality Aspects

  • Color-coding tags and UDI coding on the soft blister enable inspection by camera 
  • Suitable for both Luer slip tip and Luer lock syringes
  • Irradiation by e-beam to achieve Sterility Assurance Level of at least 10-6 
  • In compliance with all applicable ISO standards and Pharmacopoeia
  • FDA cleared
  • CE-marked  
  • Proven track record of reliable supply assured by global operating company

General specifications

​SurGuard®3 Safety Hypodermic Needles are intended for subcutaneous, intramuscular and intravenous applications.

Specification Description
Needle PointT-SharpTM Triple-bevel lancet point
CannulasStainless steel X5CrNi 18-10
HubPolypropylene + Color Masterbatch
Shipping carton (standard packaging)800 pieces (8 x 100 pieces)
SterilizationIrradiation
Shelf-life5 years

Global Solutions

SurGuard®3 Safety Hypodermic Needles solutions are available to drug product manufacturers globally. For more information about product availability, specifications, and applicable standards, download our data sheet or contact your Terumo representative today.

Please note that some products may not be available in all regions, check with your local TERUMO Pharmaceuticals Solutions contact for details. 
All brand names are trademarks or registered trademarks of TERUMO CORPORATION and their respective owners.

Downloads

Relevant product information
Datasheet_Surguard3_2020

References

1 Comparative Hypodermic Needle Sharpness Among Major Brands, 2009
Data on file
3 Valid for cannula gauges from 18G to 25G/16mm

Let’s Find Your Best Solution

Innovation and creativity are central to Terumo Pharmaceutical Solutions’ value proposition. Our expert teams lead the industry in developing and manufacturing advanced, high-performing infusion and injection technologies for all parenteral applications.

Contact Us

Didn't find your product?

Consult our products in our Product Index

Are you a pharmaceutical professional?

This information is intended for professionals in the pharmaceutical supply chain who are interested in primary packaging, injection components and medical devices from Terumo Pharmaceutical Solutions, for use in combination with their respective drug products (hereafter, pharmaceutical professionals). Please note that the product information contained on this website is exclusively addressed to pharmaceutical professionals. This product information is not for the general public, nor is it intended to be a substitute for professional medical advice or for the care that patients receive from their healthcare professionals. By accessing it, you (i) acknowledge having read and understood both the above message and our terms of use and, further, (ii) confirm that you do so in the capacity of a pharmaceutical professional.